Collegium Pharmaceutical (COLL) Leases (2019 - 2025)
Historic Leases for Collegium Pharmaceutical (COLL) over the last 7 years, with Q3 2025 value amounting to $4.4 million.
- Collegium Pharmaceutical's Leases fell 2815.69% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 2815.69%. This contributed to the annual value of $5.8 million for FY2024, which is 343.34% down from last year.
- Per Collegium Pharmaceutical's latest filing, its Leases stood at $4.4 million for Q3 2025, which was down 2815.69% from $5.3 million recorded in Q2 2025.
- Over the past 5 years, Collegium Pharmaceutical's Leases peaked at $8.2 million during Q1 2021, and registered a low of $4.4 million during Q3 2025.
- For the 5-year period, Collegium Pharmaceutical's Leases averaged around $6.6 million, with its median value being $6.5 million (2023).
- As far as peak fluctuations go, Collegium Pharmaceutical's Leases crashed by 118.53% in 2024, and later tumbled by 2815.69% in 2025.
- Collegium Pharmaceutical's Leases (Quarter) stood at $7.6 million in 2021, then fell by 10.24% to $6.9 million in 2022, then decreased by 12.13% to $6.0 million in 2023, then decreased by 3.43% to $5.8 million in 2024, then fell by 23.87% to $4.4 million in 2025.
- Its Leases was $4.4 million in Q3 2025, compared to $5.3 million in Q2 2025 and $5.5 million in Q1 2025.